Anti-Melanoma Marker (MART-1 + Tyrosinase + gp100) Mouse Monoclonal Antibody [clone: M2-7C10 + M2-9E3 + T311 + HMB45]

Supplier: Novus Biologicals
NBP2-48257
103286-916EA 515.69 USD
103286-916
Anti-Melanoma Marker (MART-1 + Tyrosinase + gp100) Mouse Monoclonal Antibody [clone: M2-7C10 + M2-9E3 + T311 + HMB45]
Antibodies
The Melanoma Marker (MART-1 + Tyrosinase + gp100) Antibody (M2-7C10 + M2-9E3 + T311 + HMB45) - IHC-Prediluted from Novus Biologicals is a mouse monoclonal antibody to Melanoma Marker (MART-1 + Tyrosinase + gp100). This antibody reacts with human. The Melanoma Marker (MART-1 + Tyrosinase + gp100) Antibody (M2-7C10 + M2-9E3 + T311 + HMB45) - IHC-Prediluted has been validated for the following applications: Immunohistochemistry-Paraffin.

Type: Primary
Antigen: Melanoma Marker (MART-1 + Tyrosinase + gp100)
Clonality: Monoclonal
Clone: M2-7C10 + M2-9E3 + T311 + HMB45
Conjugation: Unconjugated
Epitope:
Host: Mouse
Isotype: IgG2b/IgG2a/IgG1
Reactivity: Human
Order Now

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR